Value investor Bill Nygren shares his market views in an interview Thursday on CNBC's "Halftime Report." » Read More
By: Evelyn Cheng
Bitcoin surged Thursday, recovering from a sharp sell-off to briefly trade above $12,000. » Read More
The consumer discretionary sector, which was the best performer in 2015, is down over 4 percent this year. One trader's big bet the pain will continue.
Dennis Gartman says the mid $30s could be the new norm for oil.
As earnings season gets underway, a group of stocks could be poised to move higher, if history is any guide.
With stocks last week getting off to their worst ever start to a new year, investors should know the risks of ETFs, says AB's Peter Kraus.
"The Saudis have a definitive game-plan to wipe out U.S. production," CNBC's Jim Cramer says.
Check out Prothena CEO Dale Schenk's revealing update on the state of the company's pipeline and its prospects.
You may think you know what you pay in 401(k) fees, but think again. Here's how to tell, and how much you can save.
"Mad Money" host Jim Cramer takes a long look at Wall Street and finds how China, energy and a global slowdown have made this stock untouchable.
Using Kensho, a quant tool used by hedge funds, CNBC Pro searched for the best and worst performing names when copper prices plunge.
Some of the names on the move ahead of the open.
Current market volatility is part of the new normal, not a sign of a 100-year storm, Jason Trennert told CNBC.
Overnight news will likely again be key for stock market action Tuesday, as Wall Street will be watching China for any further weakening in the yuan.
It's been a grim start to the year as far as equity markets are concerned, but one strategist has told CNBC it's only a "nasty market correction."
Steve Cohen’s second corporate incarnation, Point72 Asset Management, has developed into a childhood prodigy.
The "Fast Money" traders give their final trades of the day.
Simon Lack uses the pothole analogy in the book, "Wall Street Potholes: Insights on Avoiding Dangerous Products."
Jim Cramer says the problem isn't with just Under Armour — it's all momentum stocks.
While the biotech sector has been under fire for high drug prices, Biotech CEO says that it brings innovations.
Tech companies could soon rebound from the dip that China’s markets caused them as earnings season approaches, experts said.
Short term, there are two things that are moving the markets: 1) oil, and 2) fears of a currency war.
Get the best of CNBC in your inbox